| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.01 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | 0.46 | 0.02 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | 0.077 | 0.02 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.02 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.02 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.11 | 0.02 |